The Cooper Companies Inc. (COO) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
The Cooper Companies Inc. (COO) advanced +1.57% to $60.34 as options desks priced 58% call premium vs. 42% put protection around the $59 max-pain magnet. Solid 66% profit margin (5% return on capital), mixed timing at 31x P/E—hold if owned, no rush to chase.
Since April 2026, CooperCompanies has been in a holding pattern, posting a small loss of 4% while floating around $60.41. The stock also fell short of the S&P 500’s 7.5% gain during that period.
Cooper Companies (COO) is undergoing a leadership change after Albert White stepped down as president and CEO. Board member Walter Rosebrough has stepped in as executive chair and is overseeing day-to-day operations. Rec
Weeks after an investor called for leadership changes, Cooper has parted ways with its CEO and proposed a new-look board of directors.
Cooper Companies is expected to announce its fourth-quarter earnings soon, and analysts expect a single-digit EPS fall.
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard tr
Key TakeawaysBausch + Lomb shares jumped 16% after a third-quarter profit beat and raised full-year guidance. Profit is the story: adjusted EBITDA rose 34% on 7% revenue growth.
Independent Director and Seasoned Healthcare Executive Walt Rosebrough Elected Executive Chair; Search for CEO UnderwayProvides Update on Board Refreshment, Including Planned Addition of Medical Device and Vision Veteran
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants
CooperCompanies (Nasdaq: COO) (the "Company"), a leading medical device company, today announced leadership changes and planned Board refreshment aimed at strengthening operational execution, improving business
Cooper Companies has climbed in recent weeks even though its longer term returns have been weak, which puts a spotlight on whether the current share price lines up with what its earnings justify. With fresh headlines aro
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +5.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on COO today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for COO. Explore sector supply chains on /butterfly.
Why COO Stock advanced +1.57% Today — RQD Quant Desk Flash. Solid 66% profit margin (5% return on capital), mixed timing at 31x P/E—hold if owned, no rush to chase.